Clinical relevance of smartphone apps for diabetes management: A global overview

被引:32
作者
Huang, Zhilian [1 ,2 ]
Soljak, Michael [1 ]
Boehm, Bernhard Otto [3 ]
Car, Josip [1 ]
机构
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Ctr Populat Hlth Sci, Clin Sci Bldg,Level 18,11 Mandalay Rd, Singapore 308232, Singapore
[2] Nanyang Technol Univ, Interdisciplinary Disciplinary Sch, NTU Inst Hlth Technol HlthTech NTU, Singapore, Singapore
[3] Nanyang Technol Univ, Lee Kong Chian Sch Med, Immuno Metab Lab, Singapore, Singapore
关键词
diabetes management; digital interventions; global health; health apps; mHealth;
D O I
10.1002/dmrr.2990
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We assessed the number, proportion, and clinical relevance of diabetes self-management apps in major languages spoken by 10 countries with the highest number of people with diabetes. Methods: China, India, USA, Brazil, Russian Federation, Mexico, Indonesia, Egypt, Japan, and Pakistan were identified as the 10 countries with the largest number of people with diabetes based on the latest NCD-RisC survey. Android and iOS apps in the 10 national languages were extracted with a search strategy. App titles and descriptions were systematically screened by trained reviewers, including apps specific for diabetes self-management and excluding apps for health care providers, general well-being, health and product promotion, and traditional cure. Eighteen apps in the above languages were then downloaded based on availability and popularity and assessed for clinical relevance to diabetes self-management with reference to current clinical guidelines. Results: The diabetes-related search terms identified 3374 Android and 4477 iOS apps, where 1019 Android and 1303 iOS apps were screened as being relevant for diabetes self-management. Chinese and English language apps constitute above 80% of the diabetes apps, have more downloads, and more comprehensive clinically relevant functions compared with other languages. None of the apps assessed met all criteria for information provision and app functionalities nor provided information cited from accredited sources. Conclusions: Our study showed that apps could play an important role in complementing multifaceted diabetes care, but should preferably be regulated, context specific, and more tailored to users' needs with clear guidance for patients and clinicians about the choices.
引用
收藏
页数:8
相关论文
共 26 条
[1]  
Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc09-S062, 10.2337/dc12-S064, 10.2337/dc19-S002, 10.2337/dc18-S002]
[2]  
American Diabetes Association, 2017, Diabetes Care, V40, pS88
[3]  
[Anonymous], 2015, Mobile medical applications: Guidance for industry and food and drug administration staff
[4]  
[Anonymous], 2017, GLOB PICT DIAB FACT
[5]  
[Anonymous], 2017, GROW VAL DIG HLTH EV
[6]   Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis [J].
Aslam, Aisha A. ;
Higgins, Colin ;
Sinha, Ian P. ;
Southern, Kevin W. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01)
[7]   Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Bonoto, Braulio Cezar ;
de Araujo, Vania Eloisa ;
Godoi, Isabella Piassi ;
Pires de Lemos, Livia Lovato ;
Godman, Brian ;
Bennie, Marion ;
Diniz, Leonardo Mauricio ;
Guerra Junior, Augusto Afonso .
JMIR MHEALTH AND UHEALTH, 2017, 5 (03)
[8]  
Chavez S, 2017, DIABETES CARE
[9]   FDA Regulation of Mobile Health Technologies [J].
Cortez, Nathan G. ;
Cohen, I. Glenn ;
Kesselheim, Aaron S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (04) :372-379
[10]   GENERALIZATION OF SCOTTS INDEX OF INTERCODER AGREEMENT [J].
CRAIG, RT .
PUBLIC OPINION QUARTERLY, 1981, 45 (02) :260-264